Palo Alto Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.2M | Sell |
|
|||||
|
2025
Q1 | $70.1M | Sell |
|
|||||
|
2024
Q4 | $70.2M | Sell |
|
|||||
|
2024
Q3 | $76.6M | Sell |
|
|||||
|
2024
Q2 | $93M | Sell |
|
|||||
|
2024
Q1 | $99.1M | Sell |
|
|||||
|
2023
Q4 | $145M | Sell |
|
|||||
|
2023
Q3 | $162M | Hold |
|
|||||
|
2023
Q2 | $159M | Hold |
|
|||||
|
2023
Q1 | $178M | Sell |
|
|||||
|
2022
Q4 | $195M | Sell |
|
|||||
|
2022
Q3 | $168M | Sell |
|
|||||
|
2022
Q2 | $171M | Sell |
|
|||||
|
2022
Q1 | $165M | Sell |
|
|||||
|
2021
Q4 | $196M | Hold |
|
|||||
|
2021
Q3 | $171M | Hold |
|
|||||
|
2021
Q2 | $185M | Buy |
|
|||||
|
2021
Q1 | $167M | Buy |
|
|||||
|
2020
Q4 | $189M | Buy |
|
|||||
|
2020
Q3 | $132M | Buy |
|
|||||
|
2020
Q2 | $173M | Sell |
|
|||||
|
2020
Q1 | $130M | Sell |
|
|||||
|
2019
Q4 | $171M | Sell |
|
|||||
|
2019
Q3 | $149M | Sell |
|
|||||
|
2019
Q2 | $223M | Sell |
|
|||||
|
2019
Q1 | $235M | Buy |
|
|||||
|
2018
Q4 | $218M | Buy |
|
|||||
|
2018
Q3 | $247M | Hold |
|
|||||
|
2018
Q2 | $240M | Buy |
|
|||||
|
2018
Q1 | $206M | Buy |
|
|||||
|
2017
Q4 | $223M | Buy |
|
|||||
|
2017
Q3 | $227M | Buy |
|
|||||
|
2017
Q2 | $217M | Buy |
|
|||||
|
2017
Q1 | $209M | Buy |
|
|||||
|
2016
Q4 | $162M | Buy |
|
|||||
|
2016
Q3 | $166M | Buy |
|
|||||
|
2016
Q2 | $135M | Buy |
|
|||||
|
2016
Q1 | $111M | Buy |
|
|||||
|
2015
Q4 | $140M | Sell |
|
|||||
|
2015
Q3 | $176M | Buy |
|
|||||
|
2015
Q2 | $227M | Buy |
|
|||||
|
2015
Q1 | $206M | Buy |
|
|||||
|
2014
Q4 | $118M | Buy |
|
|||||
|
2014
Q3 | $91.2M | Buy |
|
|||||
|
2014
Q2 | $57M | Buy |
|
|||||
|
2014
Q1 | $50.9M | Buy |
|
|||||
|
2013
Q4 | $52.1M | Buy |
|
|||||
|
2013
Q3 | $40.7M | Sell |
|
|||||
|
2013
Q2 | $43.9M | Buy |
|